HomeNewscoronavirusCOVID-19 vaccination | No glitch in CoWIN from the start: RS Sharma

COVID-19 vaccination | No glitch in CoWIN from the start: RS Sharma

RS Sharma calrified that the registration for COVID-19 vaccination is taking place only through Aarogya Setu app and Co-WIN’s portal cowin.gov.in.

March 01, 2021 / 21:07 IST
Story continues below Advertisement
RS Sharma, Chairman of Empowered Group on Vaccine Administration (Co-WIN).
RS Sharma, Chairman of Empowered Group on Vaccine Administration (Co-WIN).

Dismissing the "rumours" of technical glitches in Co-WIN platform, RS Sharma, Chairman of Empowered Group on Vaccine Administration (Co-WIN), on March 1 said the confusion was created by spreading misinformation that vaccination registration is being done through a mobile application.

There were rumours that people who want to book an appointment for COVID-19 vaccination should register on Co-WIN app instead of Co-WIN website.

Story continues below Advertisement

The National Heath Authority CEO clarified that the registration for vaccine is taking place only through Aarogya Setu app and Co-WIN’s portal cowin.gov.in.

Speaking to ANI, Sharma said ,"There has been no glitch right from the start. What happened was that some people spread the misinformation that there is a Co-WIN app. So, people started searching for the app which is not ours. That is why there was some confusion among the people. After clarifying there is no Co-WIN app, we have given an extension in Aarogya Setu app for registration and provided a portal ‘cowin.gov.in’.

As the second phase of nationwide vaccination drive against the coronavirus disease started on March 1, 17 lakh people have registered for the vaccination against COVID-19 so far since the morning. This system is working fine and there is no glitch, he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show